Back to Search
Start Over
Correction to: A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer.
- Source :
-
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2018 Sep; Vol. 82 (3), pp. 419. - Publication Year :
- 2018
-
Abstract
- The original version of this article unfortunately contained a mistake. The co-authors' names were incorrect.
Details
- Language :
- English
- ISSN :
- 1432-0843
- Volume :
- 82
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Cancer chemotherapy and pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 30014222
- Full Text :
- https://doi.org/10.1007/s00280-018-3641-5